Page last updated: 2024-09-02

kt 6149 and Lung Neoplasms

kt 6149 has been researched along with Lung Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardiet, C; Catimel, G; De Bruijn, E; Dirix, L; Dumortier, A; Evene, E; Joossens, E; Koier, I; Provè, A; Schrijvers, D1
Bando, T; Fujimura, M; Heki, U; Iwasa, K; Kasahara, K; Matsuda, T; Numata, Y; Shibata, K; Shirasaki, H1
Fukuoka, K; Ishida, T; Kurokawa, H; Nishio, K; Saijo, N1
Saijo, N1
Asami, N; Inaba, M; Morimoto, M; Sudo, Y; Tsuruo, T1

Reviews

2 review(s) available for kt 6149 and Lung Neoplasms

ArticleYear
[gamma-Glutamylcysteine synthetase and chemosensitivity].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:4

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutamate-Cysteine Ligase; Humans; Lung Neoplasms; Mice; Mitomycin; Mitomycins; RNA, Messenger

1997
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Chest, 1998, Volume: 113, Issue:1 Suppl

    Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

1998

Trials

1 trial(s) available for kt 6149 and Lung Neoplasms

ArticleYear
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149.
    Anti-cancer drugs, 1995, Volume: 6, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Biotransformation; Bone Marrow Diseases; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastrointestinal Diseases; Half-Life; Humans; Liver Neoplasms; Lung Diseases; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Unknown Primary; Salvage Therapy

1995

Other Studies

2 other study(ies) available for kt 6149 and Lung Neoplasms

ArticleYear
Modulation of sensitivity to mitomycin C and a dithiol analogue by tempol in non-small-cell lung cancer cell lines under hypoxia.
    Journal of cancer research and clinical oncology, 1996, Volume: 122, Issue:1

    Topics: Antineoplastic Agents; Antioxidants; Biotransformation; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Hypoxia; Cyclic N-Oxides; Cytochrome Reductases; Cytochrome-B(5) Reductase; Drug Combinations; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Mitomycin; Mitomycins; NAD(P)H Dehydrogenase (Quinone); Spin Labels; Tumor Cells, Cultured

1996
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
    Cancer chemotherapy and pharmacology, 1990, Volume: 27, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Leukemia P388; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation

1990